These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 17631392

  • 1. A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis.
    Puopolo A, Boice JA, Fidelholtz JL, Littlejohn TW, Miranda P, Berrocal A, Ko A, Cichanowitz N, Reicin AS.
    Osteoarthritis Cartilage; 2007 Dec; 15(12):1348-56. PubMed ID: 17631392
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.
    Wiesenhutter CW, Boice JA, Ko A, Sheldon EA, Murphy FT, Wittmer BA, Aversano ML, Reicin AS, Protocol 071 Study Group.
    Mayo Clin Proc; 2005 Apr; 80(4):470-9. PubMed ID: 15819283
    [Abstract] [Full Text] [Related]

  • 3. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
    Gottesdiener K, Schnitzer T, Fisher C, Bockow B, Markenson J, Ko A, DeTora L, Curtis S, Geissler L, Gertz BJ, Protocol 007 Study Group.
    Rheumatology (Oxford); 2002 Sep; 41(9):1052-61. PubMed ID: 12209041
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.
    Reginster JY, Malmstrom K, Mehta A, Bergman G, Ko AT, Curtis SP, Reicin AS.
    Ann Rheum Dis; 2007 Jul; 66(7):945-51. PubMed ID: 17142385
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM.
    Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial.
    Leung AT, Malmstrom K, Gallacher AE, Sarembock B, Poor G, Beaulieu A, Castro R, Sanchez M, Detora LM, Ng J.
    Curr Med Res Opin; 2002 Mar; 18(2):49-58. PubMed ID: 12017209
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis.
    Zacher J, Feldman D, Gerli R, Scott D, Hou SM, Uebelhart D, Rodger IW, Ozturk ZE, etoricoxib OA study group.
    Curr Med Res Opin; 2003 Mar; 19(8):725-36. PubMed ID: 14687444
    [Abstract] [Full Text] [Related]

  • 8. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
    Yoo MC, Yoo WH, Kang SB, Park YW, Kim SS, Moon KH, Song YW, Min BW, Cho YJ, Moon SH, Bin SI, Baek HJ, Shim SC, Lee SW, Yoo DH, Mehta A, Skuban A, Cukrow DM, Vandormael K, Yan L.
    Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
    [Abstract] [Full Text] [Related]

  • 9. Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].
    Curtis SP, Bockow B, Fisher C, Olaleye J, Compton A, Ko AT, Reicin AS.
    BMC Musculoskelet Disord; 2005 Dec 01; 6():58. PubMed ID: 16321158
    [Abstract] [Full Text] [Related]

  • 10. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.
    Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N.
    J Rheumatol; 2000 Nov 01; 27(11):2635-41. PubMed ID: 11093446
    [Abstract] [Full Text] [Related]

  • 11. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo.
    Bingham CO, Smugar SS, Wang H, Peloso PM, Gammaitoni A.
    Pain Med; 2011 Mar 01; 12(3):352-61. PubMed ID: 21332932
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
    van der Heijde D, Baraf HS, Ramos-Remus C, Calin A, Weaver AL, Schiff M, James M, Markind JE, Reicin AS, Melian A, Dougados M.
    Arthritis Rheum; 2005 Apr 01; 52(4):1205-15. PubMed ID: 15818702
    [Abstract] [Full Text] [Related]

  • 13. Etoricoxib in the treatment of primary dysmenorrhea in Chinese patients: a randomized controlled trial.
    Yu Q, Zhu X, Zhang X, Zhang Y, Li X, Hua Q, Chang Q, Zou Q, Di W, Yao Y, Yu W, Liu J, Mehta A, Yan L.
    Curr Med Res Opin; 2014 Sep 01; 30(9):1863-70. PubMed ID: 24960147
    [Abstract] [Full Text] [Related]

  • 14. Responder analysis and correlation of outcome measures: pooled results from two identical studies comparing etoricoxib, celecoxib, and placebo in osteoarthritis.
    Bingham CO, Bird SR, Smugar SS, Xu X, Tershakovec AM.
    Osteoarthritis Cartilage; 2008 Nov 01; 16(11):1289-93. PubMed ID: 18514551
    [Abstract] [Full Text] [Related]

  • 15. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
    Matsumoto AK, Melian A, Mandel DR, McIlwain HH, Borenstein D, Zhao PL, Lines CR, Gertz BJ, Curtis S, Etoricoxib Rheumatoid Arthritis Study Group.
    J Rheumatol; 2002 Aug 01; 29(8):1623-30. PubMed ID: 12180720
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group.
    Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, Helgetveit KB, Kress B, Daniels B, Bolognese J, Krupa D, Seidenberg B, Ehrich E.
    Arch Intern Med; 2000 Jun 26; 160(12):1781-7. PubMed ID: 10871971
    [Abstract] [Full Text] [Related]

  • 17. Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial.
    Baraf HS, Fuentealba C, Greenwald M, Brzezicki J, O'Brien K, Soffer B, Polis A, Bird S, Kaur A, Curtis SP, EDGE Study Group.
    J Rheumatol; 2007 Feb 26; 34(2):408-20. PubMed ID: 17304660
    [Abstract] [Full Text] [Related]

  • 18. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study.
    Malmstrom K, Sapre A, Couglin H, Agrawal NG, Mazenko RS, Fricke JR.
    Clin Ther; 2004 May 26; 26(5):667-79. PubMed ID: 15220011
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E, Beaulieu A, Paster Z, Dutta D, Yu S, Sloan VS.
    Clin Ther; 2005 Jan 26; 27(1):64-77. PubMed ID: 15763607
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.